NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual
Value
£39
Suppliers
- Allergan
- ACCORD-UK LTD
- Roche Products Ltd
- Sandoz Ltd
- Amgen Ltd
- Napp Pharmaceuticals Ltd
- Novo Nordisk
- Pfizer Ltd
- Vifor Pharma UK Ltd
- Ipsen
- Janssen-Cilag Ltd
- Teva UK Limited
- Almirall
- Merck Serono Limited
- Chugai Pharma UK Ltd
- Pharmacosmos UK Ltd
- Merz
- Eli Lilly and Company Ltd
- Merck Sharpe and Dohme (UK) Limited
- Zentiva Pharma UK Ltd
- Thornton and Ross Ltd
- AstraZeneca
- Bristol Myers Squibb
- GLAXOSMITHKLINE UK LIMITED
- Sobi (Swedish Orphan Biovitrum Ltd)
- Celltrion Healthcare United Kingdom Limited
- Takeda UK Ltd
- Aventis Pharma ltd t/a Sanofi
- Gedeon Richter UK Ltd
- Organon Pharmaceuticals UK Ltd
- UCB Pharma Ltd
Classifications
- Pharmaceutical products
Tags
- award
- contract
Published
3 years ago
Description
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual Tranche<br/><br/>Offer reference number: CM/PHR/20/5602<br/>CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines – Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete